Baropharm Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
55
- Stock Symbol
-
0153R0
- Investments
-
2
- Share Price
-
$4.20
- (As of Friday Closing)
Baropharm General Information
Description
BaroPharm Co operates a healthcare platform business based on IT technology that supports the efficiency of pharmaceutical ordering and management operations in pharmacies. Its key services consist of integrated pharmaceutical ordering, price and inventory comparison, payment and return notifications, and out-of-stock and restock alerts, along with functions such as pharmaceutical information search, education, community features, and management support.
Contact Information
Website
www.baropharm.comCorporate Office
- 77, Dongjak-daero
- Dongjak-gu
- Seoul
- South Korea
Corporate Office
- 77, Dongjak-daero
- Dongjak-gu
- Seoul
- South Korea
Baropharm Timeline
Baropharm Stock Performance
As of 20-Nov-2026, Baropharm’s stock price is $4.20. Its current market cap is $50.3M with 12M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.20 | $4.89 | $4.07 - $12.94 | $50.3M | 12M | 3.38M |
Baropharm Financials Summary
As of 31-Dec-2025, Baropharm has a trailing 12-month revenue of $67.9M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| Revenue | 67,949 | 67,949 | 33,347 | 8,872 |
| Total Assets | 22,096 | |||
| Total Debt | 0 |
Baropharm Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Baropharm Signals
Baropharm Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Baropharm Acquisitions (2)
Baropharm’s most recent deal was a Merger/Acquisition with CHD Pharmaceuticals. The deal was made on 01-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CHD Pharmaceuticals | 01-May-2026 | Merger/Acquisition | Other Commercial Products | ||
| Brp Labs | 01-Jan-2023 | Merger/Acquisition | Drug Discovery |
Baropharm Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Brp Labs | Incheon, South Korea | 2009 | |
| CHD Pharmaceuticals | Goyang-si, South Korea | 2003 |
Baropharm FAQs
-
When was Baropharm founded?
Baropharm was founded in 2019.
-
Where is Baropharm headquartered?
Baropharm is headquartered in Seoul, South Korea.
-
What is the size of Baropharm?
Baropharm has 55 total employees.
-
What industry is Baropharm in?
Baropharm’s primary industry is Enterprise Systems (Healthcare).
-
Is Baropharm a private or public company?
Baropharm is a Public company.
-
What is Baropharm’s stock symbol?
The ticker symbol for Baropharm is 0153R0.
-
What is the current stock price of Baropharm?
As of 20-Nov-2026 the stock price of Baropharm is $4.20.
-
What is the current market cap of Baropharm?
The current market capitalization of Baropharm is $50.3M.
-
What is Baropharm’s current revenue?
The trailing twelve month revenue for Baropharm is $67.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process